Next Quarterly Earnings
Wednesday, August 12, 2026
CW 33
After-Hours
In 38 days
Vaxcyte is a US-based, clinical-stage biotechnology company dedicated to developing innovative conjugate vaccines for the prevention of serious infectious diseases. The company focuses on novel vaccine candidates targeting bacterial pathogens to improve global health outcomes.